Survivorship and complications of treatment in breast cancer.
The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.
Mrozek
Ewa
E
Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210, USA.
Shapiro
Charles L
CL
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D020516:Brachial Plexus Neuropathies / Q000209:etiology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002318:Cardiovascular Diseases / Q000209:etiology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced; D016889:Endometrial Neoplasms / Q000139:chemically induced; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D008209:Lymphedema / Q000209:etiology / Q000628:therapy; D008408:Mastectomy; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000209:etiology; D010024:Osteoporosis / Q000139:chemically induced; D011183:Postoperative Complications / Q000209:etiology; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced; D011832:Radiation Injuries / Q000209:etiology; D017564:Radiation Pneumonitis / Q000188:drug therapy / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects* / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D017741:Survivors; D013927:Thrombosis / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D018931:Antineoplastic Agents, Hormonal